Drotaverine induced urticaria: a case report
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20251068Keywords:
Hydroisoquinolone, Antispasmodic, GI diseases, Smooth muscle spasm, Cutaneous lesionsAbstract
Drotaverine belongs to the hydroisoquinolone class of drugs. It is an effective antispasmodic drug used in the symptomatic treatment of various conditions such as GI diseases, biliary dyskinesia and smooth muscle spasms. There are a very few hypersensitivity reactions reported with this drug. Drotaverine induced cutaneous lesions is a very rare adverse effect and one such occurrence is discussed here. Diagnosis is a clinical one, made usually on the basis of knowledge obtained by medical history and physical examination.
Metrics
References
Karakus M, Pantet O, Charrière M, Favre D, Gaide O, Berger MM. Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia. Clin Nutr. 2023;42(6):859-68. DOI: https://doi.org/10.1016/j.clnu.2023.04.006
Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol. 2008;53(1):2-8. DOI: https://doi.org/10.4103/0019-5154.39732
Narang M, Shah D, Akhtar H. Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: a randomized placebo-controlled trial. Indian Pediatr. 2015;52(10):847-51. DOI: https://doi.org/10.1007/s13312-015-0730-y
Narang S, Koli J. Efficacy and safety of fixed-dose combination of drotaverine hydrochloride (80 mg) and paracetamol (500 mg) in amelioration of abdominal pain in acute infectious gastroenteritis: a randomized controlled trial. J Gastroenterol Hepatol. 2018;33(12):1942-7. DOI: https://doi.org/10.1111/jgh.14370
Ali S, Corcea SL, Cristian RM, Bumbacea RS. A rapid desensitization protocol in a case of drotaverine-induced serum sickness-like reaction in a pregnant woman: a case report. Exp Ther Med. 2019;18(6):5105-7. DOI: https://doi.org/10.3892/etm.2019.8170
Andleeb S. Evaluation of hypotension and allergic reaction with parenteral drotaverine in a tertiary care hospital. Can J Appl Sci. 2017;7:1–4. DOI: https://doi.org/10.21065/1925-7430.7.1
Gheorghe DA. Drotaverine efficacy and safety in patients with colic pain associated with irritable bowel syndrome-observational retrospective clinical study. Farmacia. 2025;73(1):222–36. DOI: https://doi.org/10.31925/farmacia.2025.1.23
Kumar Paudel P, Basnet S, Shreshtha M. Efficacy of hyoscine butylbromide versus drotaverine in relieving acute nonspecific abdominal pain in children- a non - randomized trial. J of Nepal Paed Society. 2022;42(1):45–50. DOI: https://doi.org/10.3126/jnps.v42i1.39773
Downloads
Published
How to Cite
Issue
Section
